(Q36461885)

14 August 2017

1 reference

title

Metabolic actions of adipocyte hormones: focus on adiponectin (English)

1 reference

14 August 2017

1 reference

Rexford S Ahima

1

1 reference

14 August 2017

1 February 2006

1 reference

14 August 2017

1 reference

14 August 2017

14 Suppl 1

1 reference

14 August 2017

9S-15S

1 reference

Obesity wars: molecular progress confronts an expanding epidemic

14 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Leptin regulation of neuroendocrine systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Acquired and inherited lipodystrophies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Inflammatory pathways and insulin action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Interleukin-6-deficient mice develop mature-onset obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Obesity is associated with macrophage accumulation in adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Critical review of acylation-stimulating protein physiology in humans and rodents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

A novel serum protein similar to C1q, produced exclusively in adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

AdipoQ is a novel adipose-specific gene dysregulated in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Adiponectin before and after weight loss in obese children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Linkage of Plasma Adiponectin Levels to 3q27 Explained by Association With Variation in the APM1 Gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Adiponectin acts in the brain to decrease body weight.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Adiponectin: A novel adipokine linking adipocytes and vascular function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Disruption of adiponectin causes insulin resistance and neointimal formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Positional cloning of the mouse obese gene and its human homologue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Resistin and adiponectin--of mice and men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Adiponectin but not resistin is associated with insulin resistance-related phenotypes in baboons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Leptin-replacement therapy for lipodystrophy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

Recombinant human leptin in women with hypothalamic amenorrhea.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.276

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.276

1 reference

14 August 2017

1 reference

PubMed ID

16642957